BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25997714)

  • 1. Papillary thyroid carcinoma: prognostic significance of cancer presentation.
    Choi H; Kasaian K; Melck A; Ong K; Jones SJ; White A; Wiseman SM
    Am J Surg; 2015 Aug; 210(2):298-301. PubMed ID: 25997714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma.
    Lee YM; Lee JB
    J Int Med Res; 2013 Jun; 41(3):825-34. PubMed ID: 23569038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sex on the clinicopathological characteristics and prognosis of papillary thyroid cancer.
    Yorke E; Melck A; Wiseman SM
    Can J Surg; 2016 Aug; 59(4):287-8. PubMed ID: 27454841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical importance of bilateral disease in patients with papillary thyroid cancer.
    Moore SE; Kasaian K; Jones S; Melck A; Wiseman SM
    Can J Surg; 2016 Jun; 59(3):213-5. PubMed ID: 27240287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warthin-like variant of papillary thyroid carcinoma: single institution experience.
    Jun HH; Kim SM; Hong SW; Lee YS; Chang HS; Park CS
    ANZ J Surg; 2016 Jun; 86(6):492-4. PubMed ID: 24981584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
    Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
    J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytologic features of focal papillary thyroid carcinoma arising within follicular adenoma: a masked cytomorphologic analysis of 17 cases.
    Ono JC; Wilbur DC; Lee H; Yang J; Krane JF; Bongiovanni M; Faquin WC
    Acta Cytol; 2011; 55(6):531-8. PubMed ID: 22156462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
    Brennan K; Holsinger C; Dosiou C; Sunwoo JB; Akatsu H; Haile R; Gevaert O
    BMC Cancer; 2016 Sep; 16(1):736. PubMed ID: 27633254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
    Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA
    Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
    Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
    Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.
    Niederer-Wüst SM; Jochum W; Förbs D; Brändle M; Bilz S; Clerici T; Oettli R; Müller J; Haile SR; Ess S; Stoeckli SJ; Broglie MA
    Surgery; 2015 Jan; 157(1):119-25. PubMed ID: 25482468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship and clinical significance between mutated BRAF with prophylactic central-neck nodal dissection in papillary thyroid carcinoma].
    Zhang YJ; Liu BG; Zhao ZY; Sheng JD; Feng DD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):502-6. PubMed ID: 27318915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
    Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
    Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
    Elisei R; Viola D; Torregrossa L; Giannini R; Romei C; Ugolini C; Molinaro E; Agate L; Biagini A; Lupi C; Valerio L; Materazzi G; Miccoli P; Piaggi P; Pinchera A; Vitti P; Basolo F
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4390-8. PubMed ID: 23066120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.
    Hay ID; Bergstralh EJ; Goellner JR; Ebersold JR; Grant CS
    Surgery; 1993 Dec; 114(6):1050-7; discussion 1057-8. PubMed ID: 8256208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous Prognoses for pT3 Papillary Thyroid Carcinomas and Impact of Delayed Risk Stratification.
    Tavarelli M; Sarfati J; Chereau N; Tissier F; Golmard JL; Ghander C; Lussey-Lepoutre C; Trésallet C; Menegaux F; Leenhardt L; Buffet C
    Thyroid; 2017 Jun; 27(6):778-786. PubMed ID: 28351220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.